Vera Therapeutics (VERA) Research & Development (2020 - 2026)
Vera Therapeutics (VERA) posted Research & Development of $86.0 million for Q1 2026, up 45.02% on a QoQ basis from $59.3 million in Q4 2025, and up 108.37% year-over-year from $41.3 million in Q1 2025.
Vera Therapeutics (VERA) Research & Development (2020 - 2026) Analysis & Trends
Vera Therapeutics' Research & Development history runs 7 years deep, the most recent figure standing at $86.0 million for Q1 2026.
- Quarterly Research & Development rose 108.37% year-over-year to $86.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $260.0 million (up 80.24% YoY) and the FY2025 annual result came in at $215.3 million, up 70.61% from the prior year.
- Research & Development was $86.0 million for Q1 2026 at Vera Therapeutics, up from $59.3 million in the prior quarter.
- Across five years, Research & Development topped out at $86.0 million in Q1 2026 and bottomed at $3.7 million in Q3 2022.
- A 5-year average of $35.1 million and a median of $29.3 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development jumped 2490.81% — and 2023, when it sank 68.17%.
- Vera Therapeutics' Research & Development stood at $65.3 million in 2022, then sank by 68.17% to $20.8 million in 2023, then surged by 60.44% to $33.3 million in 2024, then soared by 77.86% to $59.3 million in 2025, then surged by 45.02% to $86.0 million in 2026.
- Business Quant data shows VERA's Research & Development at $86.0 million in Q1 2026, $59.3 million in Q4 2025, and $56.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Vera Therapeutics | 2.55 Bn | 2.55 Bn | - | 86.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.01 Mn |
| Dec 31, 2025 | 59.31 Mn |
| Sep 30, 2025 | 56.47 Mn |
| Jun 30, 2025 | 58.20 Mn |
| Mar 31, 2025 | 41.28 Mn |
| Dec 31, 2024 | 33.35 Mn |
| Sep 30, 2024 | 40.31 Mn |
| Jun 30, 2024 | 29.31 Mn |
| Mar 31, 2024 | 23.20 Mn |
| Dec 31, 2023 | 20.79 Mn |
| Sep 30, 2023 | 16.10 Mn |
| Jun 30, 2023 | 16.23 Mn |
| Mar 31, 2023 | 25.11 Mn |
| Dec 31, 2022 | 65.29 Mn |
| Sep 30, 2022 | 3.70 Mn |
| Jun 30, 2022 | 10.11 Mn |
| Mar 31, 2022 | 12.55 Mn |
| Dec 31, 2021 | -2.73 Mn |
| Sep 30, 2021 | 3.56 Mn |
| Jun 30, 2021 | 3.24 Mn |